Clik here to view.
Antisoma Adopts Therex From Imperial Cancer Research Fund
Antisoma PLC has adopted a new clinical programme around Therex, a product based on the humanised monoclonal antibody huHMFG1 aiming to treat breast cancer. Originally developed by the Imperial Cancer...
View ArticleClik here to view.
Nutraceutix Licenses Subsidiary Of Boehringer-ingelheim To Market Calcium...
Nutraceutix, Inc. has licensed Quest Vitamins, a subsidiary of Boehringer-Ingelheim, (Canada) Ltd. the non-exclusive right to distribute health supplement products containing the patented dietary...
View ArticleClik here to view.
Curagen And Gemini Enter Genome Wide Drug Target Discovery And...
CuraGen Corporation, an integrated genomics based drug discovery and development company, and Gemini Genomics plc, announced today the largest collaboration to date linking cSNPs (human genetic...
View ArticleClik here to view.
Progenics And Cytogen Announce Progress On Vaccine And Antibody Therapies For...
Progenics Pharmaceuticals, Inc. and Cytogen Corporation have announced new findings on immune therapies which may play a future role in the treatment of prostate and other cancers. The therapies are...
View ArticleClik here to view.
ImClone And DAKO To Develop Screening Kit
ImClone Systems Incorporated and DAKO Corporation have entered into an agreement for the development of an Epidermal Growth Factor receptor (EGFr) screening kit. EGFr is a receptor associated with...
View ArticleClik here to view.
Applied Imaging And Rigshospitalet University Agree Collaboration
Applied Imaging Corp. has teamed with Drs. Hans Skovgaard Poulsen and Jens Benn Sorensen from the Department of Oncology at the Rigshospitalet University of Copenhagen, Denmark, to optimize and...
View ArticleClik here to view.
Diagnostic Products And Minerva Sign Development Agreement
Diagnostic Products Corp. and Minerva Pharmaceuticals Inc. have entered into a license agreement for the development of immunoassays for a newly described malignancy protein. Minerva Pharmaceuticals...
View ArticleBiopulse Acquires Cancer Vaccine
BioPulse International, Inc. has acquired a new and improved method of creating dendritic cell cancer vaccines. “Antigens associated with cancerous tumours are not normally recognized by the immune...
View ArticleClik here to view.
Idun And Abbott Extend Partnership Agreement
Idun Pharmaceuticals, Inc. has extended their worldwide research and development agreement with Abbott Laboratories focusing on the discovery and development of products to treat people with cancer....
View ArticleClik here to view.
Cell Pathways And Squibb Agree Joint Study
Cell Pathways, Inc. and Bristol-Myers Squibb Company plan to cooperate in supporting a clinical trial to study the combination of Aptosyn (exisulind) and TAXOL (paclitaxel) plus Paraplatin...
View Article
